APPLIED DNA SCIENCES INC (APDN)

US03815U4094 - Common Stock

0.1771  -0.01 (-5.29%)

After market: 0.1778 +0 (+0.4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025
Revenue
YoY % growth
18.169M
101.25%
13.367M
-26.43%
3.431M
-74.33%
5.309M
54.72%
EBITDA
YoY % growth
-12.68M
-10.75%
-9.591M
24.36%
-13.328M
-38.97%
N/A
EBIT
YoY % growth
-13.97M
-13.64%
-10.953M
21.60%
-14.025M
-28.05%
-13.431M
4.23%
Operating Margin
-76.89%-81.94%-408.72%-252.98%
EPS
YoY % growth
-20.00
48.77%
-15.00
25.00%
-6.96
53.60%
-1.07
84.69%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.33
81.58%
-0.29
94.62%
-0.24
-151.00%
-0.23
28.28%
Revenue
Q2Q % growth
1.058M
18.72%
1.124M
20.91%
1.487M
86.57%
1.742M
115.06%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-3.513M
7.29%
-3.567M
1.41%
-3.159M
5.61%
-2.996M
8.42%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-0.32
93.85%
-0.350.037.73%
Q3 2024
Q2Q % growth
0.47
109.79%
-0.360.83231.65%
Q2 2024
Q2Q % growth
-5.31
-631.00%
-4.59-0.72-15.69%
Q1 2024
Q2Q % growth
-1.80
70.00%
-6.324.5271.54%
Q4 2023
Q2Q % growth
-5.20
-2,500.00%
-5.510.315.59%
Q3 2023
Q2Q % growth
-4.80
-84.62%
-4.900.101.96%
Q2 2023
Q2Q % growth
1.00
121.74%
-4.085.08124.51%
Q1 2023
Q2Q % growth
-6.00
52.38%
-5.92-0.08-1.42%
Q4 2022
Q2Q % growth
-0.20
98.34%
-5.305.1096.23%
Q3 2022
Q2Q % growth
-2.60
71.74%
-7.244.6464.10%
Q2 2022
Q2Q % growth
-4.60
30.30%
-6.802.2032.35%
Q1 2022
Q2Q % growth
-12.60
-12.50%
-5.44-7.16-131.61%
Q4 2021
Q2Q % growth
-12.04
22.82%
-7.62-4.42-58.09%
Q3 2021
Q2Q % growth
-9.20
36.11%
-5.37-3.83-71.26%
Q2 2021
Q2Q % growth
-6.60
58.23%
-4.35-2.25-51.66%
Q1 2021
Q2Q % growth
-11.20
50.00%
-11.02-0.18-1.67%
Q4 2020
Q2Q % growth
-15.60
70.34%
-10.61-4.99-47.06%
Q3 2020
Q2Q % growth
-14.40
55.00%
-13.77-0.63-4.58%
Q2 2020
Q2Q % growth
-15.80
75.31%
-15.71-0.09-0.59%
Q1 2020
Q2Q % growth
-22.40
74.55%
-25.302.9011.45%
Q4 2019
Q2Q % growth
-52.60
45.21%
-25.70-26.90-104.64%
Q3 2019
Q2Q % growth
-32.00
60.00%
-20.40-11.60-56.86%
Q2 2019
Q2Q % growth
-64.00
-14.29%
-73.449.4412.85%
Q1 2019
Q2Q % growth
-88.00
8.33%
-65.28-22.72-34.80%
Q4 2018
Q2Q % growth
-96.00 -28.56-67.44-236.13%
Q3 2018
Q2Q % growth
-80.00 -40.80-39.20-96.08%
Q2 2018
Q2Q % growth
-56.00 -97.9241.9242.81%
Q1 2018
Q2Q % growth
-96.00 -89.76-6.24-6.95%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
810K
3.85%
916.98K-106.98K-11.67%
Q3 2024
Q2Q % growth
797K
-72.68%
1.101M-304K-27.61%
Q2 2024
Q2Q % growth
929.63K
-78.91%
970.02K-40.39K-4.16%
Q1 2024
Q2Q % growth
891.16K
-83.07%
791.52K99.64K12.59%
Q4 2023
Q2Q % growth
780K
-78.09%
1.632M-852K-52.21%
Q3 2023
Q2Q % growth
2.917M
-32.10%
2.609M308.34K11.82%
Q2 2023
Q2Q % growth
4.408M
-28.29%
4.208M200K4.75%
Q1 2023
Q2Q % growth
5.263M
26.34%
4.253M1.01M23.74%
Q4 2022
Q2Q % growth
3.559M
17.09%
4.187M-627.7K-14.99%
Q3 2022
Q2Q % growth
4.296M
152.68%
3.673M623.4K16.97%
Q2 2022
Q2Q % growth
6.147M
130.11%
4.589M1.558M33.96%
Q1 2022
Q2Q % growth
4.166M
157.76%
4.1M65.7K1.60%
Q4 2021
Q2Q % growth
3.04M
868.06%
2.342M697.7K29.79%
Q3 2021
Q2Q % growth
1.7M
294.04%
3.191M-1.491M-46.72%
Q2 2021
Q2Q % growth
2.672M
383.53%
2.653M18.5K0.70%
Q1 2021
Q2Q % growth
1.616M
155.11%
1.387M229.1K16.52%
Q4 2020
Q2Q % growth
314K
-81.23%
721.65K-407.65K-56.49%
Q3 2020
Q2Q % growth
431.5K
-78.99%
818.04K-386.54K-47.25%
Q2 2020
Q2Q % growth
552.5K
-29.03%
964.92K-412.42K-42.74%
Q1 2020
Q2Q % growth
633.5K
-28.36%
761.94K-128.44K-16.86%
Q4 2019
Q2Q % growth
1.673M
39.94%
2.156M-483.2K-22.41%
Q3 2019
Q2Q % growth
2.054M
102.04%
3.607M-1.554M-43.07%
Q2 2019
Q2Q % growth
778.5K
-25.43%
1.348M-569.5K-42.25%
Q1 2019
Q2Q % growth
884.3K
36.53%
1.26M-375.7K-29.82%
Q4 2018
Q2Q % growth
1.195M 1.913M-717.6K-37.51%
Q3 2018
Q2Q % growth
1.016M 2.805M-1.789M-63.76%
Q2 2018
Q2Q % growth
1.044M 918K126K13.73%
Q1 2018
Q2Q % growth
647.7K 1.704M-1.056M-61.99%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%